Purchase textbook

Therapeutic Targets for Diabetic Retinopathy,

Edition 1 A Translational Approach

Editors: By Weiye Li, MD, PhD and Jingfa Zhang, MD, PhD

Publication Date: 11 Jan 2023

0 Reviews

Conformance

PDF/UA-1
The publication was certified on 20250728
For queries regarding accessibility information, contact [email protected]

Ways Of Reading

This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation.

Navigation

The contents of the PDF have been tagged to permit access by assistive technologies as per PDF-UA-1 standard.
Page breaks included from the original print source

Additional Accessibility Information

The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

Note

This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.

Therapeutic Targets For Diabetic Retinopathy: A Translational Approach offers a consolidated view of this complex disorder by summarizing the latest evidence-based studies and translating their findings into practical, actionable knowledge. This concise resource covers the fundamentals of diabetic retinopathy and diabetic macular edema with an emphasis on basic science and therapeutic targets on the horizon. Ophthalmologists, optometrists, and researchers will find the translational approach to this common eye disorder to be useful in both research and clinical practice settings.

Key Features

Takes a concise yet comprehensive approach to diabetic eye disorders, covering basic science as well as therapeutic agents with both current and future clinical applications
Covers current diagnostic and management guidelines as well developments on the horizon that are likely to improve patient outcomes
Explains the pathophysiological mechanisms of diabetic retinopathy and diabetic macular edema from both a basic and clinical perspective, helping readers seek promising new therapeutic targets
Consolidates today's available information on this timely topic into a single, convenient resource

About the author

By Weiye Li, MD, PhD, Professor emeritus of Ophthalmology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA and Jingfa Zhang, MD, PhD, Associate Chief Physician, Associate Professor, Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai, China

1. Introduction of diabetic retinopathy and principles of treatment
2. Diabetes-induced metabolic disorders of diabetic retinopathy
3. Diabetic retinopathy, a neurovascular unit disease
4. The pathogenic role of apoptosis in the development of diabetic retinopathy
5. Diabetic retinopathy, a disease with low-grade inflammation
6. Neurodegeneration and microangiopathy in diabetic retina and choroid
7. Proliferative diabetic retinopathy, a disease of pathologic angiogenesis and vasculogenesis
8. Pathogenesis of diabetic macular edema
9. Treatments for diabetic retinopathy and diabetic macular edema in pipeline
10. Future perspectives for diabetic retinopathy management

Therapeutic Targets for Diabetic Retinopathy,

Editors: By Weiye Li, MD, PhD and Jingfa Zhang, MD, PhD

Description

Key Features

About the author